Can an employer dismiss me for a positive drug test if I have a valid cannabis prescription?

Potentially, yes — particularly in safety-sensitive roles. A valid prescription establishes that you possessed the medicine lawfully, but workplace health and safety law in Australia places an independent obligation on workers to be fit for duty. Fair Work Commission decisions have addressed this on a case-by-case basis; the outcome depends on your specific role, employer policy, industry, and state jurisdiction. An employment lawyer and your occupational health team are the right starting points.

Will a CBD-only product make me test positive at work?

Standard workplace immunoassay tests target THC and its metabolite THC-COOH, not CBD itself. A genuine CBD isolate product containing no THC would not be expected to trigger a positive result. However, full-spectrum products retain trace THC, and product labelling is not always a reliable guide to actual composition. If your role involves drug testing, this is worth discussing with your prescribing doctor and the occupational health team at your workplace.

How long does THC stay detectable after taking prescribed cannabis?

It varies considerably. In oral fluid (saliva) tests, THC is typically detectable for hours to around 24–48 hours after use, though this depends on the dose, formulation, and individual metabolism. In urine, the metabolite THC-COOH can be detected for days to several weeks in regular users. There is no fixed 'safe window' that applies universally — the pharmacokinetics are specific to the product and the individual.

Does disclosing my prescription before a drug test change the outcome?

Disclosure to an occupational health provider is generally advisable in roles where you have a duty to report medications that may affect safety. Whether it changes the outcome of a positive test depends entirely on the employer's policy, the applicable industrial instrument, and the industry. In some non-safety-critical contexts it can inform a more nuanced response; in aviation, mining, or rail it is unlikely to override a zero-tolerance detection policy.

Is it legal to drive in Australia while taking prescribed cannabis?

In most Australian states and territories, roadside drug testing laws make it an offence to drive with a detectable concentration of THC in your oral fluid — regardless of whether you hold a valid prescription. Some jurisdictions are considering or have proposed medical-use defences, but at the time of writing the legal protections for prescribed patients vary significantly by state, and in most jurisdictions a positive roadside test can result in licence sanctions even if the cannabis was lawfully prescribed. Seek current legal advice specific to your state.

Workplace Drug Testing and Prescribed Medicines

By Marcus Hale · 26 June 2026 · 7 min read

Large building with many columns and cars parked outside

About once a fortnight, someone finds this site through a search that reads something like "prescribed cannabis + drug test + job." It's one of the most practically consequential regulatory questions in this space, and the short version is: a valid prescription does not exempt you from a positive workplace drug test result, and the legal framework here is genuinely complicated.

Let me walk through how it actually works.

How prescribed cannabis sits under Australian scheduling law

Cannabis-derived products prescribed in Australia are classified under the Poisons Standard (the document that gives effect to the Therapeutic Goods Administration's scheduling decisions) as either Schedule 4 (Prescription Only) or, more commonly for products containing tetrahydrocannabinol (THC) above certain thresholds, Schedule 8 (Controlled Drug). Schedule 8 sits alongside morphine and oxycodone. That is not a moral judgement , it's a regulatory one, reflecting the psychoactive potential of THC and the additional record-keeping obligations placed on prescribers and pharmacists.

Cannabidiol (CBD) at prescription doses is Schedule 4. A low-dose CBD product (≤150 mg/day for adults, specific criteria apply) was down-scheduled to Schedule 3 (Pharmacist Only) in 2021, making it available over the counter. But most patients prescribed medicinal cannabis through the Special Access Scheme or an Authorised Prescriber pathway are using Schedule 8 products , and those products contain THC.

THC is the cannabinoid that standard workplace oral fluid and urine immunoassay tests are designed to detect.

What workplace drug testing actually measures

Most Australian workplace drug tests use oral fluid (saliva) screening, often following the AS/NZS 4760:2019 standard. That standard was revised specifically to bring oral fluid testing methodology in line with what's now required under the National Standard for Traffic Enforcement Agencies and various state-based heavy vehicle and mine-site regimes. Urine testing is also used, particularly in Commonwealth employment contexts.

These tests detect the presence of delta-9-THC (in oral fluid) or its primary metabolite THC-COOH (in urine). They do not assess impairment. They detect the molecule, or its metabolic by-product, up to certain detection thresholds , and here's where prescribed patients run into trouble.

THC can remain detectable in urine for days to several weeks in a regular user, depending on body composition, frequency of use, and the pharmacokinetics of the specific formulation. Oral fluid detection windows are shorter; typically hours to a couple of days, but that varies considerably too. A person who took their prescribed medication the evening before an early morning test may still return a positive oral fluid result.

The test does not know, and cannot distinguish, whether THC came from a Schedule 8 prescription or from illicit use.

Does a valid prescription protect you legally?

This is where I'd urge people to be genuinely careful with advice found on forums and social media. The answer is: it depends on the legal framework that applies to you, and "having a prescription" is not a blanket legal shield.

Under most state and territory road transport laws, driving with a detectable concentration of THC in your oral fluid is an offence regardless of prescription status. New South Wales, Victoria, Queensland, Western Australia, South Australia, Tasmania and the ACT all operate roadside drug testing regimes where a positive oral fluid result for THC can lead to licence sanctions, irrespective of whether the person holds a valid prescription. Some states have been slower than others to carve out medical defences; at the time of writing, the legal landscape remains patchy and is the subject of ongoing law reform discussion at the state level.

In the workplace context, the position is different but still not simple. Workplace health and safety legislation; primarily the Work Health and Safety Act 2011 (Cth) and its state equivalents, places duties on both employers and workers. An employer in a safety-critical environment (mining, construction, transport) can require a worker to be fit for duty and can enforce drug-testing policies as part of that obligation. A positive test result, even from a lawfully prescribed medication, can trigger a "not fit for work" finding under those policies. The prescription speaks to the lawfulness of possession; it does not automatically resolve the fitness-for-work question.

I'll be honest: I think this is one area where Australian regulatory reform has lagged behind the clinical reality of how prescribed cannabis is actually used. That's my view, and the various parliamentary inquiries into medicinal cannabis access have raised similar concerns. But the law is what it is right now.

The employer's obligation and the duty of disclosure

Workers in safety-sensitive roles typically have an obligation to disclose prescribed medications that may affect their capacity to perform work safely. This is not specific to cannabis, it applies to opioids, benzodiazepines, and other Schedule 8 and Schedule 4 medicines. The practical question for someone prescribed a THC-containing product is whether and how to disclose to an occupational health provider, and what accommodation (if any) the employer can offer.

Some employers, particularly in industries without strict safety-critical classifications, have developed more nuanced approaches; assessing impairment rather than mere detection. But in mining, aviation, rail and heavy road transport, zero-tolerance detection-based policies remain common and are often underpinned by industrial instruments or specific safety regulations.

Occupational physicians and workplace health teams are the right people to navigate the disclosure and accommodation question. That's not a dodge, it's genuinely a clinical and legal assessment that requires knowing the specific role, the specific employer policy, the specific product, and the applicable state law.

What about CBD-only products?

A legitimate question. Standard immunoassay workplace tests are calibrated for THC and THC-COOH; they are not typically designed to detect CBD. A pure CBD isolate product, with no detectable THC, would not be expected to return a positive result on a standard drug screen.

The complication arises with full-spectrum products. Full-spectrum extracts, by definition, retain the range of cannabinoids present in the plant, including THC, typically at low levels. Depending on the formulation and the dose taken, cumulative THC exposure from a full-spectrum product could theoretically reach detectable concentrations. This is a pharmacokinetic question that's product-specific and not one I can answer in general terms.

Broad-spectrum products are processed to remove THC while retaining other cannabinoids, and isolates contain only the single purified compound. But labelling claims and actual product composition are not always in perfect alignment; the TGA has taken enforcement action against suppliers making unsubstantiated claims, and product quality in the over-the-counter CBD space still warrants scrutiny.

The reform picture

The Senate Community Affairs References Committee has examined medicinal cannabis access on multiple occasions, and the intersection with road and workplace drug testing has come up consistently. The Therapeutic Goods Administration's medicinal cannabis guidance (published at tga.gov.au) notes the detection window issue, though stops well short of endorsing any particular approach for patients in safety-sensitive employment.

Several state governments have flagged road law reform to create medical defences for lawfully prescribed patients, but progress has been uneven. Victoria has moved furthest in publicly acknowledging the tension. At the Commonwealth level, the Drug and Alcohol Framework for Commonwealth Workplaces is under the remit of Comcare and the relevant portfolio department.

I spent a couple of Saturday mornings last month cross-referencing the AS/NZS 4760:2019 standard against recent Fair Work Commission decisions on workplace drug testing, which, I'll admit, is probably not everyone's idea of a good weekend, but Trevor the sourdough starter only needs attention twice a day, so there's time. The case law from the Commission is genuinely instructive on how arbiters are weighing positive test results against prescription evidence; a pattern of "not automatically determinative" reasoning is emerging, though it's still very fact-specific.

The regulatory picture here is unfinished. Patients, prescribers, employers, and regulators are all operating in a framework that predates the modern medicinal cannabis access scheme by decades. The scheduling and access law has moved; the drug testing and transport law has moved more slowly. That gap is where most of the practical difficulty lives.

Sources

, Marcus Hale, Regulatory researcher; TGA & access law

]]>

Common questions

Can an employer dismiss me for a positive drug test if I have a valid cannabis prescription?: Potentially, yes — particularly in safety-sensitive roles. A valid prescription establishes that you possessed the medicine lawfully, but workplace health and safety law in Australia places an independent obligation on workers to be fit for duty. Fair Work Commission decisions have addressed this on a case-by-case basis; the outcome depends on your specific role, employer policy, industry, and state jurisdiction. An employment lawyer and your occupational health team are the right starting points.
Will a CBD-only product make me test positive at work?: Standard workplace immunoassay tests target THC and its metabolite THC-COOH, not CBD itself. A genuine CBD isolate product containing no THC would not be expected to trigger a positive result. However, full-spectrum products retain trace THC, and product labelling is not always a reliable guide to actual composition. If your role involves drug testing, this is worth discussing with your prescribing doctor and the occupational health team at your workplace.
How long does THC stay detectable after taking prescribed cannabis?: It varies considerably. In oral fluid (saliva) tests, THC is typically detectable for hours to around 24–48 hours after use, though this depends on the dose, formulation, and individual metabolism. In urine, the metabolite THC-COOH can be detected for days to several weeks in regular users. There is no fixed 'safe window' that applies universally — the pharmacokinetics are specific to the product and the individual.
Does disclosing my prescription before a drug test change the outcome?: Disclosure to an occupational health provider is generally advisable in roles where you have a duty to report medications that may affect safety. Whether it changes the outcome of a positive test depends entirely on the employer's policy, the applicable industrial instrument, and the industry. In some non-safety-critical contexts it can inform a more nuanced response; in aviation, mining, or rail it is unlikely to override a zero-tolerance detection policy.
Is it legal to drive in Australia while taking prescribed cannabis?: In most Australian states and territories, roadside drug testing laws make it an offence to drive with a detectable concentration of THC in your oral fluid — regardless of whether you hold a valid prescription. Some jurisdictions are considering or have proposed medical-use defences, but at the time of writing the legal protections for prescribed patients vary significantly by state, and in most jurisdictions a positive roadside test can result in licence sanctions even if the cannabis was lawfully prescribed. Seek current legal advice specific to your state.